Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: The European Male Aging Study (EMAS)

Dirk Vanderschueren, Stephen R. Pye, Terence W. O'Neill, David M. Lee, Ivo Jans, Jaak Billen, Evelien Gielen, Michaël Laurent, Frank Claessens, Judith E. Adams, Kate A. Ward, G. Bártfai, Felipe F. Casanueva, Joseph D. Finn, Gianni Forti, Aleksander Giwercman, Thang S. Han, Ilpo T. Huhtaniemi, Krzysztof Kula, Michael E J LeanNeil Pendleton, Margus Punab, Frederick C W Wu, Steven Boonen

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Context: There is little information on the potential impact of serum 1,25-dihydroxyvitamin D [1,25(OH)2D] on bone health including turnover. Objective: The objective of the study was to determine the influence of 1,25(OH)2D and 25-hydroxyvitamin D [25(OH)D] on bone health in middle-aged and older European men. Design, Setting, and Participants: Men aged 40-79 years were recruited from population registers in 8 European centers. Subjects completed questionnaires that included questions concerning lifestyle and were invited to attend for quantitative ultrasound (QUS) of the heel, assessment of height and weight, and a fasting blood sample from which 1,25(OH)2D, 25(OH)D, and PTH were measured. 1,25(OH)2D was measured using liquid chromatography tandem mass spectrometry. Bone markers serum N-terminal propeptide of type 1 procollagen (P1NP) and crosslinks (β-cTX) were also measured. Dual-energy x-ray absorptiometry (DXA) of the hip and lumbar spine was performed in 2 centers. Main Outcome Measure(s):QUSof the heel, bone markers P1NP and β-cTX, and DXA of the hip and lumbar spine were measured. Results: A total of 2783 men, mean age 60.0 years (SD 11.0) were included in the analysis. After adjustment for age and center, 1,25(OH) 2D was positively associated with 25(OH)D but not with PTH. 25(OH)D was negatively associated with PTH. After adjustment for age, center, height, weight, lifestyle factors, and season, 1,25(OH)2D was associated negatively with QUS and DXA parameters and associated positively with β-cTX. 1,25(OH)2D was not correlated with P1NP. 25(OH)D was positively associated with the QUS and DXA parameters but not related to eitherbone turnover marker. Subjects with both high 1,25(OH)2D (upper tertile) and low 25(OH)D (lower tertile) had the lowest QUS and DXA parameters and the highest β-cTX levels. Conclusions: Serum 1,25(OH)2D is associated with higher bone turnover and poorer bone health despite being positively related to 25(OH)D. A combination of high 1,25(OH)2D and low 25(OH)D is associated with the poorest bone health.

Original languageEnglish
Pages (from-to)995-1005
Number of pages11
JournalJournal of Clinical Endocrinology and Metabolism
Volume98
Issue number3
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Vitamin D
Bone
Aging of materials
X-Rays
Health
Bone and Bones
X rays
Ultrasonics
Life Style
Hip
Spine
Weights and Measures
Calcaneus
Heel
Bone Remodeling
Collagen Type I
Tandem Mass Spectrometry
Serum
Liquid Chromatography
Registries

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men : The European Male Aging Study (EMAS). / Vanderschueren, Dirk; Pye, Stephen R.; O'Neill, Terence W.; Lee, David M.; Jans, Ivo; Billen, Jaak; Gielen, Evelien; Laurent, Michaël; Claessens, Frank; Adams, Judith E.; Ward, Kate A.; Bártfai, G.; Casanueva, Felipe F.; Finn, Joseph D.; Forti, Gianni; Giwercman, Aleksander; Han, Thang S.; Huhtaniemi, Ilpo T.; Kula, Krzysztof; Lean, Michael E J; Pendleton, Neil; Punab, Margus; Wu, Frederick C W; Boonen, Steven.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 98, No. 3, 03.2013, p. 995-1005.

Research output: Contribution to journalArticle

Vanderschueren, D, Pye, SR, O'Neill, TW, Lee, DM, Jans, I, Billen, J, Gielen, E, Laurent, M, Claessens, F, Adams, JE, Ward, KA, Bártfai, G, Casanueva, FF, Finn, JD, Forti, G, Giwercman, A, Han, TS, Huhtaniemi, IT, Kula, K, Lean, MEJ, Pendleton, N, Punab, M, Wu, FCW & Boonen, S 2013, 'Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: The European Male Aging Study (EMAS)', Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 3, pp. 995-1005. https://doi.org/10.1210/jc.2012-2772
Vanderschueren, Dirk ; Pye, Stephen R. ; O'Neill, Terence W. ; Lee, David M. ; Jans, Ivo ; Billen, Jaak ; Gielen, Evelien ; Laurent, Michaël ; Claessens, Frank ; Adams, Judith E. ; Ward, Kate A. ; Bártfai, G. ; Casanueva, Felipe F. ; Finn, Joseph D. ; Forti, Gianni ; Giwercman, Aleksander ; Han, Thang S. ; Huhtaniemi, Ilpo T. ; Kula, Krzysztof ; Lean, Michael E J ; Pendleton, Neil ; Punab, Margus ; Wu, Frederick C W ; Boonen, Steven. / Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men : The European Male Aging Study (EMAS). In: Journal of Clinical Endocrinology and Metabolism. 2013 ; Vol. 98, No. 3. pp. 995-1005.
@article{74acc8a650224623a24c3a424dea906e,
title = "Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: The European Male Aging Study (EMAS)",
abstract = "Context: There is little information on the potential impact of serum 1,25-dihydroxyvitamin D [1,25(OH)2D] on bone health including turnover. Objective: The objective of the study was to determine the influence of 1,25(OH)2D and 25-hydroxyvitamin D [25(OH)D] on bone health in middle-aged and older European men. Design, Setting, and Participants: Men aged 40-79 years were recruited from population registers in 8 European centers. Subjects completed questionnaires that included questions concerning lifestyle and were invited to attend for quantitative ultrasound (QUS) of the heel, assessment of height and weight, and a fasting blood sample from which 1,25(OH)2D, 25(OH)D, and PTH were measured. 1,25(OH)2D was measured using liquid chromatography tandem mass spectrometry. Bone markers serum N-terminal propeptide of type 1 procollagen (P1NP) and crosslinks (β-cTX) were also measured. Dual-energy x-ray absorptiometry (DXA) of the hip and lumbar spine was performed in 2 centers. Main Outcome Measure(s):QUSof the heel, bone markers P1NP and β-cTX, and DXA of the hip and lumbar spine were measured. Results: A total of 2783 men, mean age 60.0 years (SD 11.0) were included in the analysis. After adjustment for age and center, 1,25(OH) 2D was positively associated with 25(OH)D but not with PTH. 25(OH)D was negatively associated with PTH. After adjustment for age, center, height, weight, lifestyle factors, and season, 1,25(OH)2D was associated negatively with QUS and DXA parameters and associated positively with β-cTX. 1,25(OH)2D was not correlated with P1NP. 25(OH)D was positively associated with the QUS and DXA parameters but not related to eitherbone turnover marker. Subjects with both high 1,25(OH)2D (upper tertile) and low 25(OH)D (lower tertile) had the lowest QUS and DXA parameters and the highest β-cTX levels. Conclusions: Serum 1,25(OH)2D is associated with higher bone turnover and poorer bone health despite being positively related to 25(OH)D. A combination of high 1,25(OH)2D and low 25(OH)D is associated with the poorest bone health.",
author = "Dirk Vanderschueren and Pye, {Stephen R.} and O'Neill, {Terence W.} and Lee, {David M.} and Ivo Jans and Jaak Billen and Evelien Gielen and Micha{\"e}l Laurent and Frank Claessens and Adams, {Judith E.} and Ward, {Kate A.} and G. B{\'a}rtfai and Casanueva, {Felipe F.} and Finn, {Joseph D.} and Gianni Forti and Aleksander Giwercman and Han, {Thang S.} and Huhtaniemi, {Ilpo T.} and Krzysztof Kula and Lean, {Michael E J} and Neil Pendleton and Margus Punab and Wu, {Frederick C W} and Steven Boonen",
year = "2013",
month = "3",
doi = "10.1210/jc.2012-2772",
language = "English",
volume = "98",
pages = "995--1005",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men

T2 - The European Male Aging Study (EMAS)

AU - Vanderschueren, Dirk

AU - Pye, Stephen R.

AU - O'Neill, Terence W.

AU - Lee, David M.

AU - Jans, Ivo

AU - Billen, Jaak

AU - Gielen, Evelien

AU - Laurent, Michaël

AU - Claessens, Frank

AU - Adams, Judith E.

AU - Ward, Kate A.

AU - Bártfai, G.

AU - Casanueva, Felipe F.

AU - Finn, Joseph D.

AU - Forti, Gianni

AU - Giwercman, Aleksander

AU - Han, Thang S.

AU - Huhtaniemi, Ilpo T.

AU - Kula, Krzysztof

AU - Lean, Michael E J

AU - Pendleton, Neil

AU - Punab, Margus

AU - Wu, Frederick C W

AU - Boonen, Steven

PY - 2013/3

Y1 - 2013/3

N2 - Context: There is little information on the potential impact of serum 1,25-dihydroxyvitamin D [1,25(OH)2D] on bone health including turnover. Objective: The objective of the study was to determine the influence of 1,25(OH)2D and 25-hydroxyvitamin D [25(OH)D] on bone health in middle-aged and older European men. Design, Setting, and Participants: Men aged 40-79 years were recruited from population registers in 8 European centers. Subjects completed questionnaires that included questions concerning lifestyle and were invited to attend for quantitative ultrasound (QUS) of the heel, assessment of height and weight, and a fasting blood sample from which 1,25(OH)2D, 25(OH)D, and PTH were measured. 1,25(OH)2D was measured using liquid chromatography tandem mass spectrometry. Bone markers serum N-terminal propeptide of type 1 procollagen (P1NP) and crosslinks (β-cTX) were also measured. Dual-energy x-ray absorptiometry (DXA) of the hip and lumbar spine was performed in 2 centers. Main Outcome Measure(s):QUSof the heel, bone markers P1NP and β-cTX, and DXA of the hip and lumbar spine were measured. Results: A total of 2783 men, mean age 60.0 years (SD 11.0) were included in the analysis. After adjustment for age and center, 1,25(OH) 2D was positively associated with 25(OH)D but not with PTH. 25(OH)D was negatively associated with PTH. After adjustment for age, center, height, weight, lifestyle factors, and season, 1,25(OH)2D was associated negatively with QUS and DXA parameters and associated positively with β-cTX. 1,25(OH)2D was not correlated with P1NP. 25(OH)D was positively associated with the QUS and DXA parameters but not related to eitherbone turnover marker. Subjects with both high 1,25(OH)2D (upper tertile) and low 25(OH)D (lower tertile) had the lowest QUS and DXA parameters and the highest β-cTX levels. Conclusions: Serum 1,25(OH)2D is associated with higher bone turnover and poorer bone health despite being positively related to 25(OH)D. A combination of high 1,25(OH)2D and low 25(OH)D is associated with the poorest bone health.

AB - Context: There is little information on the potential impact of serum 1,25-dihydroxyvitamin D [1,25(OH)2D] on bone health including turnover. Objective: The objective of the study was to determine the influence of 1,25(OH)2D and 25-hydroxyvitamin D [25(OH)D] on bone health in middle-aged and older European men. Design, Setting, and Participants: Men aged 40-79 years were recruited from population registers in 8 European centers. Subjects completed questionnaires that included questions concerning lifestyle and were invited to attend for quantitative ultrasound (QUS) of the heel, assessment of height and weight, and a fasting blood sample from which 1,25(OH)2D, 25(OH)D, and PTH were measured. 1,25(OH)2D was measured using liquid chromatography tandem mass spectrometry. Bone markers serum N-terminal propeptide of type 1 procollagen (P1NP) and crosslinks (β-cTX) were also measured. Dual-energy x-ray absorptiometry (DXA) of the hip and lumbar spine was performed in 2 centers. Main Outcome Measure(s):QUSof the heel, bone markers P1NP and β-cTX, and DXA of the hip and lumbar spine were measured. Results: A total of 2783 men, mean age 60.0 years (SD 11.0) were included in the analysis. After adjustment for age and center, 1,25(OH) 2D was positively associated with 25(OH)D but not with PTH. 25(OH)D was negatively associated with PTH. After adjustment for age, center, height, weight, lifestyle factors, and season, 1,25(OH)2D was associated negatively with QUS and DXA parameters and associated positively with β-cTX. 1,25(OH)2D was not correlated with P1NP. 25(OH)D was positively associated with the QUS and DXA parameters but not related to eitherbone turnover marker. Subjects with both high 1,25(OH)2D (upper tertile) and low 25(OH)D (lower tertile) had the lowest QUS and DXA parameters and the highest β-cTX levels. Conclusions: Serum 1,25(OH)2D is associated with higher bone turnover and poorer bone health despite being positively related to 25(OH)D. A combination of high 1,25(OH)2D and low 25(OH)D is associated with the poorest bone health.

UR - http://www.scopus.com/inward/record.url?scp=84874858114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874858114&partnerID=8YFLogxK

U2 - 10.1210/jc.2012-2772

DO - 10.1210/jc.2012-2772

M3 - Article

C2 - 23386642

AN - SCOPUS:84874858114

VL - 98

SP - 995

EP - 1005

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -